Compare Cassava Sciences Inc (FLNA) vs ProShares Ultra Semiconductors (USD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs ProShares Ultra Semiconductors — how do they compare? Cassava Sciences Inc trades at $1.06 (market cap $53.14M), while ProShares Ultra Semiconductors trades at $85. The key difference: ProShares Ultra Semiconductors is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | USD | |
|---|---|---|
Market Cap | $53.14M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $4.64 | $113.53 |
52-Week Low | $1.09 | $39.58 |
Enterprise Value | -$33.43M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
USD stock is trading at $84.87, down 10.56% over the past 24 hours, with technical indicators showing a bearish trend. The stock faces resistance at $96 and support at $88, while moving averages signal selling pressure. Recent corporate actions include a scheduled dividend payment of $0.14 per share in June 2026. Financial ratios remain undisclosed in current data, limiting fundamental assessment.
The outlook for USD stock appears cautious due to technical bearish signals and limited fundamental visibility. Investment opportunities may arise if the stock stabilizes above key support levels, but risks include ongoing selling pressure and lack of recent financial disclosures. Investors should await updated earnings reports for clearer valuation insights.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About ProShares Ultra Semiconductors
USD is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Semiconductors™ Index. It is a tactical instrument designed for sophisticated traders looking to magnify short-term bullish views on the U.S. semiconductor industry, specifically focusing on large-cap leaders in the chip and equipment space.
Read more on USD →
